Pioneer of Transplantation, Navigation with Trial
A leading blood and oncology medical center in central and southern Taiwan, providing patients with high-quality medical services through rich transplant experience, innovative transplant methods, strong clinical trial capabilities, and connection to advanced international treatment plans.
Department Introduction
The Hematology and Oncology Department is patient-centered, offering personalized precision medicine to treat various blood disorders, as well as solid tumors such as head and neck cancer, breast cancer, gastrointestinal cancer, urinary tract cancer, and sarcomas. As the center with the richest transplant experience in central and southern Taiwan, we actively develop novel hematopoietic stem cell transplant methods to improve success rates and reduce side effects. Utilizing cutting-edge technology for molecular testing, genetic studies, and Phase I clinical trials ensures accessibility for patients, providing targeted therapy, immunotherapy, and cellular therapy for cancer patients. At the same time, we actively participate in international multi-center clinical trials to access the latest global drugs and medical technologies.
.png)
.png)
Innovative Research and Development
1. CIK for leukemia Treatment
Utilizing the patient's own immune cells enhanced through ex vivo cultivation and reinfused back, CIK cells can directly kill tumor cells, secrete anti-cancer cytokines, and enhance the overall immune response with minimal side effects. This immunotherapy is suitable for leukemia that are unresponsive to standard treatments.
2. AI-Assisted Comprehensive Chemotherapy Care
A chemotherapy care process centered on AI technology is established, covering steps such as physician prescription, pharmacist dispensing, and nursing administration. This enhances prescription safety, provides detailed documentation and management of drug side effects, and optimizes the patient care experience.
3. Immune Reconstruction Monitoring
After hematopoietic stem cell transplantation, regular monitoring of blood cell subpopulations and immunoglobulin levels is conducted to assess immune function recovery. This helps predict infection risks, guides the use of immunosuppressants, and aids in vaccination, ultimately improving transplant success rates and reducing the risk of complications, helping patients achieve optimal treatment outcomes.
.jpg)
Service
Disease
▪︎ Hematologic Malignancies : Anemia, leukemia, lymphoma, multiple myeloma, coagulation disorders.
▪︎ Solid Tumors : Head and neck cancer, thyroid cancer, esophageal cancer, breast cancer, gastric and pancreatic cancer, colorectal cancer, urinary tract cancer, sarcoma, cancer immunotherapy.
Symptoms
▪︎ Anemia : Typically accompanied by fatigue, dizziness, palpitations, and shortness of breath. These symptoms are mainly caused by insufficient red blood cell production or excessive destruction, affecting blood oxygen supply.
▪︎ Abnormal White Blood Cells : Characterized by frequent infections, recurrent fever, and even unexplained inflammatory reactions, commonly seen in leukemia patients.
▪︎ Thrombocytopenia : Manifesting as bleeding tendencies, including bruising on the skin, bleeding from the gums or nose, and even bleeding without external injury.
▪︎ Lymphadenopathy : One of the hallmarks of cancer, especially lymphoma, with painless swelling commonly felt in the neck, armpits, and groin.
▪︎ Systemic Symptoms : Including weight loss, loss of appetite, fever, and night sweats, which may result from tumor-released cytokines, reflecting the systemic impact of cancer.
Recommended Physicians
▪︎ Hematologic Malignancies (such as leukemia, lymphoma, multiple myeloma, and blood coagulation disorders) : Dr. Su-Peng Yeh、Dr. Tzu-Ting Chen、Dr. Ching-Chan Lin、Dr. Che-Hung Lin、Dr. Chi-Ching Chen、Dr. Fu-Ming Cheng、Dr.Sing-Ting Wang、Dr. Chia-Yu Chen、Dr. Yu-Min Liao
▪︎ Hematopoietic Stem Cell Transplantation (for leukemia, lymphoma, multiple myeloma patients) : Dr. Su-Peng Yeh、Dr. Tzu-Ting Chen、Dr. Ching-Chan Lin、Dr. Che-Hung Lin、Dr. Chi-Ching Chen、Dr. Fu-Ming Cheng、Dr.Sing-Ting Wang、Dr. Chia-Yu Chen
▪︎ Head and Neck Cancer : Dr. Ching-Yun Hsieh、Dr. Ming-Yu Lien、Dr. Chia-Yu Chen
▪︎ Thyroid Cancer : Dr. Chen-Yuan Lin
▪︎ Esophageal Cancer : Dr. Chen-Yuan Lin、Dr. Ming-Yu Lien、Dr. Chen Chi-Ching
▪︎ Breast Cancer : Dr. Chang-Fang Chiu、Dr. Fu-Ming Cheng、Dr. Chia-Yu Chen、Dr. Wang Sing-Ting
▪︎ Gastric and Pancreatic Cancer : Dr. Li-Yuan Bai、Dr. Chi-Ching Chen、Dr. Hsiu-Tzu Wang
▪︎ Colorectal Cancer : Dr. Che-Hung Lin、Dr. Yu-Min Liao
▪︎ Urinary Tract Cancer : Dr. Su-Peng Yeh、Dr. Ching-Chan Lin、Dr. Che-Hung Lin、Dr. Fu-Ming Cheng
▪︎ Malignant Sarcoma : Dr. Hsiu-Tzu Wang
▪︎ Cancer Immunotherapy : Dr. Li-Yuan Bai、Dr. Chen-Yuan Lin
▪︎ New Drug Clinical Trials : Dr. Li-Yuan Bai、Dr. Su-Peng Yeh
Our Teams
Quick view (click to expand)
Director
Li-Yuan Bai, M.D., Ph.D., is the director of Division of Hematology and Oncology, and the deputy director of Clinical Trial Center at China Medical University Hospital, Taichung, Taiwan.
The interest fields of professor Bai include cancer of gastrointestinal tract, pancreas, biliary tract, gastrointestinal stromal tumor, and neuroendocrine tumor. He has participated many international clinical trials in relevant fields and is the leading principle investigator in three PI-initiated, multicenter clinical trials. Prof. Bai is also active in first-in-human and early phase clinical trials, with the engagement of 34 first-in-human or phase I trials between 2014 to 2022.
Superintendent
Chang-Fang Chiu, M.D., Ph.D., is currently the Director of the Cancer Center at China Medical University Hospital. He completed his training at the renowned Memorial Sloan Kettering Cancer Center in New York, USA.
Dr. Chiu possesses extensive experience in the diagnosis and treatment of various malignant tumors and hematological diseases. He established a patient-centered, multidisciplinary team approach to care, which is applied to over twenty major cancer types. He also built a comprehensive hematopoietic stem cell transplantation care system, dedicated to providing patients with high-quality medical care.
Director
Dr. Su-Peng Yeh served as the Secretary-General of the Taiwanese Society of Hematopoietic Stem Cell Transplantation and has been an Executive Director of the Society since 2010. He is currently the Vice Superintendent of the Department of Internal Medicine at our hospital.
Dr. Yeh specializes in hematopoietic stem cell (bone marrow) transplantation, with over 100 successful transplant cases under his belt. He is also proficient in various cancer chemotherapies and transfusion medicine. In 2006, Dr. Yeh spent a year at MD Anderson Cancer Center in the United States, focusing his research on gene therapy for breast cancer.
Furthermore, Dr. Yeh actively participates in numerous clinical trials for hematologic malignancies and rare blood disorders. He is a key member of the Steering Committee for several of these trials and is the physician with the most extensive experience in CAR-T cell therapy at our hospital.
Attending Physician
Chen-Yuan Lin, M.D., Ph.D., is a physician in the Hematology and Oncology Department at China Medical University Hospital. He specializes in treating various cancers, particularly esophageal cancer, and leads multiple clinical trials.
He is responsible for teaching and mentoring physicians and pharmacists, with a research focus on the tumor immune microenvironment and personalized tumor antigens. Leveraging his experience with high-dose interleukin-2 and immune checkpoint inhibitors, Dr. Lin is dedicated to enhancing the precision of immunotherapy and developing more effective cancer treatment strategies.targeting cancer cells and ultimately achieving more precise treatment outcomes.
Attending Physician
Dr. Hsieh Ching-Yun is an attending physician in Hematology and Oncology at the China Medical University Hospital.
Dr. Hsieh’s clinical research interests mainly focus on brain tumors, head and neck cancers, and lymphoma. He has participated in numerous international clinical trials related to these diseases and has also led two investigator-initiated clinical trials. Dr. Hsieh is highly active in early-phase clinical trials for anti-cancer drugs, having been involved in numerous anti-cancer drug clinical trials. Additionally, he participated in two Phase I clinical trials for intra-tumoral drug injections.
Attending Physician
Dr. Ching-Chan Lin received his MD degree and PhD from China Medical University. He has served as an attending physician in the Division of Hematology and Oncology at China Medical University Hospital since 2010. He specializes in genitourinary cancers, hematologic malignancies, and hematopoietic stem cell transplantation. He is a member of the Taiwan Society of Internal Medicine, Chinese Society of Hematology, Chinese Society of Blood and Bone Marrow Transplantation, and Chinese Society of Oncology.
Attending Physician
Dr. Ming-Yu Lien, an attending physician at China Medical University Hospital's Hema-Oncology Department, is a Ph.D. holder and associate professor specializing in head and neck, nasopharyngeal, and esophageal cancers. As Vice Secretary-General of the Taiwan Head and Neck Society in 2024, he frequently speaks at major conferences and leads numerous clinical trials, highlighting his leadership in academia and clinical research.
Attending Physician
Dr. Tzu-Ting Chen graduated from China Medical University School of Medicine and completed her residency training at China Medical University Hospital. She has served as an attending physician in the Division of Hematology and Oncology since 2014, and as the Director of Blood Bank since 2021. She specializes in hematologic malignancy treatment and hematopoietic stem cell transplantation, and is a member of the Taiwan Society of Internal Medicine, Chinese Society of Hematology, Oncology, and Blood and Marrow Transplantation.
Attending Physician
Currently serving as an attending physician in the Division of Hematology and Oncology at China Medical University Hospital, with a medical degree from National Yang-Ming University. Specializes in hematologic diseases and malignancies such as leukemia, lymphoma, and multiple myeloma, with extensive experience in cancer treatment, particularly colorectal cancer and urological tumors. Formerly a research physician in hematology-oncology, dedicated to integrating clinical expertise with innovative therapies to provide personalized, high-quality care for patients.
Attending Physician
Chi-Ching Chen, M.D., is currently the attending physician of the division of Hematology and Oncology at China Medical University Hospital. He completed his hematology and oncology training at the China Medical University Hospital, Taiwan. He is currently pursuing a Ph.D program for aging.
Dr. Chen possesses extensive experience in the diagnosis and treatment of various malignant tumors and hematological diseases. He specializes in gastrointestinal cancers (esophagus, stomach, biliary tract, pancreas and colon), blood diseases, leukemia and hematopoietic stem cell transplantation. He follows a patient-centered, multi-specialty team care model and is committed to providing patients with personalized and high-quality medical care.
Dr. Yu-Min Liao specializes in the care of breast cancer, colorectal cancer and head-and-neck cancer. He completed his residency in internal medicine and fellowship in medical oncology and hematology at China Medical University Hospital and received clinical training at City of Hope cancer center US.
Dr. Liao has a strong interest in improving the quality of life of cancer survivors through important lifestyle interventions. He provides delicate care for both his active treatment patients as well as those in the survivorship phase of care
Attending Physician
Dr. Fu-Ming Cheng is currently an attending physician in the Hematology and Oncology Department at China Medical University Hospital. He graduated from the School of Medicine at China Medical University and has obtained board certifications in oncology, hematology, and bone marrow transplantation. He specializes in the diagnosis and treatment of general hematological diseases (such as anemia), lymphoma, leukemia, myeloma, bone marrow transplantation, breast cancer, kidney cancer, bladder cancer, and prostate cancer. Dr. Cheng is committed to the philosophy of patiently listening to patients' needs and designing personalized treatment plans for each patient.
Dr. Sing-Ting Wang completed her internal medicine and hematology-oncology subspecialty training at China Medical University Hospital. She specializes in hematological diseases, hematologic malignancies, hematopoietic stem cell transplantation, and breast cancer treatment and care. With extensive clinical experience, Dr. Wang is dedicated to delivering high-quality medical services. She employs a multidisciplinary team approach to tailor the best treatment strategies for her patients, helping them improve their quality of life.
Attending Physician
Dr. Hsiu-Tzu Wang graduated from the School of Medicine at China Medical University and received comprehensive clinical training at the China Medical University Hospital after graduation.
Her areas of expertise include solid tumors, particularly soft tissue sarcoma, osteosarcoma, gastric cancer, pancreatic cancer, biliary tract cancer, colorectal cancer, breast cancer, and gynecological cancers. She is a member physician of the Taiwan Oncology Society and the Taiwan Hospice Organization.
Dr. Chia-Yu Chen is currently an attending physician in the Department of Hematology and Oncology at China Medical University Hospital.
She graduated from China Medical University with a double major in Chinese and Western Medicine and has obtained professional certifications in oncology, hematology, and bone marrow transplantation. Her primary focus is on the treatment of breast cancer, head and neck cancer, and hematologic disorders. She is actively involved in multidisciplinary teams for breast cancer, head and neck cancer, lymphoma, and hematopoietic stem cell transplantation. Committed to a patient-centered approach, Dr. Chen strives to deliver high-quality medical care while continuously participating in clinical research to advance medical techniques and improve care for her patients.
Attending Physician
Hematologic malignancy, bone marrow transplantation
Breast cancer
Director
Li-Yuan Bai, M.D., Ph.D., is the director of Division of Hematology and Oncology, and the deputy director of Clinical Trial Center at China Medical University Hospital, Taichung, Taiwan.
The interest fields of professor Bai include cancer of gastrointestinal tract, pancreas, biliary tract, gastrointestinal stromal tumor, and neuroendocrine tumor. He has participated many international clinical trials in relevant fields and is the leading principle investigator in three PI-initiated, multicenter clinical trials. Prof. Bai is also active in first-in-human and early phase clinical trials, with the engagement of 34 first-in-human or phase I trials between 2014 to 2022.
Superintendent
Chang-Fang Chiu, M.D., Ph.D., is currently the Director of the Cancer Center at China Medical University Hospital. He completed his training at the renowned Memorial Sloan Kettering Cancer Center in New York, USA.
Dr. Chiu possesses extensive experience in the diagnosis and treatment of various malignant tumors and hematological diseases. He established a patient-centered, multidisciplinary team approach to care, which is applied to over twenty major cancer types. He also built a comprehensive hematopoietic stem cell transplantation care system, dedicated to providing patients with high-quality medical care.
Director
Dr. Su-Peng Yeh served as the Secretary-General of the Taiwanese Society of Hematopoietic Stem Cell Transplantation and has been an Executive Director of the Society since 2010. He is currently the Vice Superintendent of the Department of Internal Medicine at our hospital.
Dr. Yeh specializes in hematopoietic stem cell (bone marrow) transplantation, with over 100 successful transplant cases under his belt. He is also proficient in various cancer chemotherapies and transfusion medicine. In 2006, Dr. Yeh spent a year at MD Anderson Cancer Center in the United States, focusing his research on gene therapy for breast cancer.
Furthermore, Dr. Yeh actively participates in numerous clinical trials for hematologic malignancies and rare blood disorders. He is a key member of the Steering Committee for several of these trials and is the physician with the most extensive experience in CAR-T cell therapy at our hospital.
Switch
Homepage
facebook
IG
Other Hospital
CMUH App
Facebook
IG
YouTube